Detecting AD markers in blood samples
AI device for detecting Alzheimer's biomarkers in blood and fluids using plasmonic surfaces to enhance optical signals for accurate diagnosis.
A device for detecting protein biomarkers of Alzheimer's disease (AD) by analyzing the optical signature of blood samples and other peripheral fluids using artificial intelligence (AI) algorithms. The product will include the functionalization of plasmonic surfaces to specifically recognize the target molecules and refine the spectroscopy signals acquired.